GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Odonate Inc (OTCPK:ODTC) » Definitions » 3-Year RORE %

Odonate (Odonate) 3-Year RORE % : 0.00% (As of Sep. 2021)


View and export this data going back to 2017. Start your Free Trial

What is Odonate 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Odonate's 3-Year RORE % for the quarter that ended in Sep. 2021 was 0.00%.

The industry rank for Odonate's 3-Year RORE % or its related term are showing as below:

ODTC's 3-Year RORE % is not ranked *
in the Diversified Financial Services industry.
Industry Median: -4.37
* Ranked among companies with meaningful 3-Year RORE % only.

Odonate 3-Year RORE % Historical Data

The historical data trend for Odonate's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odonate 3-Year RORE % Chart

Odonate Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
3-Year RORE %
Get a 7-Day Free Trial - - - 32.14 1.90

Odonate Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.64 1.90 -2.89 -10.46 -15.24

Competitive Comparison of Odonate's 3-Year RORE %

For the Shell Companies subindustry, Odonate's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odonate's 3-Year RORE % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Odonate's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Odonate's 3-Year RORE % falls into.



Odonate 3-Year RORE % Calculation

Odonate's 3-Year RORE % for the quarter that ended in Sep. 2021 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -26900--43600 )/( -109600-0 )
=16700/-109600
=-15.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2021 and 3-year before.


Odonate  (OTCPK:ODTC) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Odonate 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Odonate's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Odonate (Odonate) Business Description

Traded in Other Exchanges
N/A
Address
3 East 28th Street, 10th Floor, New York, NY, USA, 10016
Odonate Inc is a Shell company.
Executives
Ecor1 Capital, Llc 10 percent owner 357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Boxer Capital, Llc director, 10 percent owner 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Kevin C Tang director, 10 percent owner, officer: Chief Executive Officer 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Aaron I. Davis director, 10 percent owner 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Craig A Johnson director C/O PURE BIOSCIENCE, 1725 GILLESPIE WAY, EL CAJON CA 92020
Jeff L Vacirca director 4747 EXECUTIVE DRIVE, SUITE 510, SAN DIEGO CA 92121
Laura L. Johnson director C/O LA JOLLA PHARMACEUTICAL COMPANY, LA JOLLA VILLAGE DRIVE, SUITE 1070, SAN DIEGO CA 92122
Michael S Hearne officer: Chief Financial Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Joseph P O'connell officer: Chief Medical Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Boxer Asset Management Inc. 10 percent owner CAY HOUSE, EP TAYLOR DRIVE N7776, LYFORD CAY, NEW PROVIDENCE C5 00000
Robert Rosen director C/O HERON THERAPEUTICS, INC, 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO CA 92121
Joseph Lewis 10 percent owner PO BOX N7776, LYFORD BAHAMAS
Tang Capital Management Llc 10 percent owner 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Tang Capital Partners Lp 10 percent owner 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
John G Lemkey officer: Chief Financial Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121

Odonate (Odonate) Headlines

From GuruFocus

Weekly CEO Buys Highlight

By Joy Hu Joy Hu 12-28-2020

Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $4.2 million of Shares

By GuruFocus Research GuruFocus Editor 12-23-2020